A detailed history of Retirement Group, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Retirement Group, LLC holds 600 shares of ACAD stock, worth $8,874. This represents 0.0% of its overall portfolio holdings.

Number of Shares
600
Previous 600 -0.0%
Holding current value
$8,874
Previous $18,000 38.89%
% of portfolio
0.0%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 09, 2022

BUY
$16.79 - $27.09 $1,679 - $2,709
100 Added 20.0%
600 $2,000
Q3 2021

Nov 16, 2021

SELL
$15.78 - $24.77 $615 - $966
-39 Reduced 7.24%
500 $2,000
Q4 2020

Feb 22, 2021

BUY
$41.04 - $56.79 $11,696 - $16,185
285 Added 112.2%
539 $28,000
Q3 2020

Nov 16, 2021

SELL
$36.42 - $57.0 $8,959 - $14,022
-246 Reduced 49.2%
254 $10,000
Q3 2020

Sep 08, 2021

BUY
$36.42 - $57.0 $18,210 - $28,500
500 New
500 $2,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Retirement Group, LLC Portfolio

Follow Retirement Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Retirement Group, LLC with notifications on news.